MDxHealth signs U.S. marketing partnership for cancer test

BRUSSELS, July 29 Mon Jul 29, 2013 2:18am EDT

Related Topics

BRUSSELS, July 29 (Reuters) - Belgium-based cancer testing company MDxHealth said on Monday it had signed a partnership with Bostwick Laboratories Inc to market prostate cancer test ConfirmMDx in the United States.

MDxHealth, which secured U.S. approval for the test earlier this month, said the partnership would grant it access to one of the largest urology networks in the country.

Bostwick provides laboratory services specialising in the monitoring and diagnosis of cancer. (Reporting By Philip Blenkinsop; editing by Robin Emmott)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.